Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer - Wikidata - awgldk - TriplyDB

Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer

Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer

http://www.wikidata.org/entity/Q28236034

about

Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint Predictive value of CHFR and MLH1 methylation in human gastric cancer.Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis.The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain.Hypermethylation and aberrant expression of Wnt antagonist secreted frizzled-related protein 1 in gastric cancer Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced NSCLC RNF8-dependent histone ubiquitination during DNA damage response and spermatogenesis Regulation of the DNA damage response by ubiquitin conjugation.The auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cells.Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a.Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation.Small molecule inhibition of the CHFR-PARP1 interaction as novel approach to overcome intrinsic taxane resistance in cancer Beyond Field Effect: Analysis of Shrunken Centroids in Normal Esophageal Epithelia Detects Concomitant Esophageal Adenocarcinoma.CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC.Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer CHFR: A Novel Mitotic Checkpoint Protein and Regulator of Tumorigenesis.Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer.CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer.Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.Enhanced genomic instabilities caused by deregulated microtubule dynamics and chromosome segregation: a perspective from genetic studies in mice.Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine.Epigenetic alterations in gastric cancer (Review).Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer Characterizing DNA methylation patterns in pancreatic cancer genome.Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis.Association between CHFR gene hypermethylation and gastric cancer risk: a meta-analysis Cancer DNA methylation: molecular mechanisms and clinical implications.Clinicopathological significance of CHFR methylation in non-small cell lung cancer: a systematic review and meta-analysis.The inhibition of UBC13 expression and blockage of the DNMT1-CHFR-Aurora A pathway contribute to paclitaxel resistance in ovarian cancer.Clinicopathological significance of CHFR promoter methylation in gastric cancer: a meta-analysis.Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum.

P2860

Q24652321-CBEBB6BB-0E79-4DE8-9DA2-7B7A9FD64FD1 Q27852998-1D3EFD7C-582B-4BEF-AF2F-1F8861B7E1D5 Q30433036-3E7B86F8-825F-4E55-BE1D-5A0FACD13A2B Q33323380-B8059748-0162-4615-8E5C-D4A04CD48E75 Q34098916-10EFFC29-49E4-4F5A-8037-FDC4A4151085 Q34168437-6280F49E-D39F-4417-A6EE-98C55825455E Q34183784-5715D2FF-061C-43D0-8282-B1536DA8B4EB Q34829400-9C1668DE-2B51-48EC-A8FB-4CCCD202369B Q35161624-579F4E83-166F-4C7F-90D0-81D0C6B77A3C Q35182916-3EB76EA4-FD9F-418E-AF46-EF1D603B74A5 Q35356744-5BE26FB6-0965-49BF-A53E-4874C4C33485 Q35882785-A0FA7E38-1FEA-46C1-A005-3A5068DD6806 Q35921557-24B72683-D461-4DF9-845C-FBA575AEE54B Q36544421-211600A7-3689-4572-AD8A-E2C1B1F17A8F Q36570795-75F78D3F-ED84-48AD-B0DF-39E4110ABD80 Q36698563-E89166C6-C679-478E-A3B1-9902F89407F4 Q36818078-5DBF9857-CBC9-4437-819E-DCCA481466D1 Q36831407-32F60434-72FC-49BE-9829-571752956B81 Q37203411-E59E21A0-A85C-4DF2-A908-32A41699FE8B Q37315455-664F72B7-EFD5-469B-BEE3-8DEA2207C693 Q37328459-3F434A68-1363-4EA9-9BDF-FEACC5B0BD75 Q37329182-EBD5DA8E-7715-4E8A-9345-81F906D596F3 Q37705684-690D17A9-F4BF-4968-8E8B-9F2BD61EBE0C Q38495706-243EE79F-C33B-4C62-AF94-80DB030EE924 Q39008172-060BB6AB-66C2-4DEC-AA4F-18183FE8FACF Q39842549-D787FB2A-1A6E-4940-9274-E06C6DA1AB3C Q41205616-5BFA9AA0-EE63-44E9-AEBE-D2F3421B8048 Q41947888-349167B5-4335-4AA9-8E02-85E1DA84FBAA Q42573635-C6D13FD2-5271-4FF7-BF0C-A9D4DE5A8FF5 Q47193635-6AA426AF-D3CC-45F1-B1FB-3BC12F0CA9E6 Q49724590-95821237-CF7E-4D33-8A20-507F6D7FD807 Q52728019-65984583-0510-487D-9908-F899411E166C Q55092089-B4B168BD-5D2F-403B-B91B-4A9B32221BF2

P2860

Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer

http://www.wikidata.org/entity/Q28236034

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Epigenetic inactivation of CHF ...... e inhibitors in gastric cancer

@ast

Epigenetic inactivation of CHF ...... e inhibitors in gastric cancer

@en

Epigenetic inactivation of CHF ...... e inhibitors in gastric cancer

@nl

type

label

Epigenetic inactivation of CHF ...... e inhibitors in gastric cancer

@ast

Epigenetic inactivation of CHF ...... e inhibitors in gastric cancer

@en

Epigenetic inactivation of CHF ...... e inhibitors in gastric cancer

@nl

prefLabel

Epigenetic inactivation of CHF ...... e inhibitors in gastric cancer

@ast

Epigenetic inactivation of CHF ...... e inhibitors in gastric cancer

@en

Epigenetic inactivation of CHF ...... e inhibitors in gastric cancer

@nl

P1433

Q28236034-9B64B941-CC40-4AFA-B615-F1D36419C0B7

P1476

Q28236034-1B75219E-C01A-4C09-8E1C-21E35B9FC8D9

P2093

Q28236034-29F8EBAF-E216-4F42-93E1-F7679641E99E

Q28236034-40B1A42F-D264-4BC9-B72E-D7861B13A25E

Q28236034-4B65307E-E4B4-40DD-8BE7-BE9CB89518D7

Q28236034-4D60F4A8-9D26-4851-BA3E-B5BA375814DF

Q28236034-58031F2D-018D-4616-B346-BE6F26C7228A

Q28236034-63E83D2C-2A30-4FFF-8F29-A2639CD8F854

Q28236034-79EEE972-0EE6-4F89-8E7A-C5158372608E

Q28236034-7BBB554E-78C9-403E-B808-882B8DF0EBFC

Q28236034-84086338-9E38-4A30-B139-644D551442F9

Q28236034-8958F03A-507A-4792-82C4-1D840A115676

P304

Q28236034-400BEA35-EB07-4AF8-B1B9-9C954FF8EC2D

P31

Q28236034-84D1124C-2178-48B2-8D9E-6B051A1EE13F

P407

Q28236034-D6B53C77-A2B8-46FB-AD9E-CB74371F5BEB

P433

Q28236034-5A06CB1D-0118-4E68-B204-E7FD158A5397

P478

Q28236034-1CE536A3-BA85-472C-8E21-52E576E41202

P50

Q28236034-EA7E5EE9-FF22-43CC-A93D-5D14E6846740

P577

Q28236034-780401C1-AE43-48D2-9A94-80C2C3A20430

P698

Q28236034-519968D1-D160-462C-82C6-DE106ECCFA56

P921

Q28236034-B6CF465F-F6A8-4DE0-B248-BAD6DCCEBDEC

P1433

Cancer Research

P1476

Epigenetic inactivation of CHF ...... e inhibitors in gastric cancer

@en

P2093

Ayumi Satoh

http://www.w3.org/2001/XMLSchema#string

Fumio Itoh

http://www.w3.org/2001/XMLSchema#string

Hiroaki Mita

http://www.w3.org/2001/XMLSchema#string

Hiromu Suzuki

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Ogi

http://www.w3.org/2001/XMLSchema#string

Kohzoh Imai

http://www.w3.org/2001/XMLSchema#string

Masahiro Fujita

http://www.w3.org/2001/XMLSchema#string

Masanobu Kusano

http://www.w3.org/2001/XMLSchema#string

Masao Hosokawa

http://www.w3.org/2001/XMLSchema#string

Minoru Toyota

http://www.w3.org/2001/XMLSchema#string

P304

8606-8613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14695171

http://www.w3.org/2001/XMLSchema#string

P921